Biodesix Inc. (BDSX) Misses Q3 EPS by 110c

Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($1.16), $1.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $20.83 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Anthropic agrees to $45bn cloud computing deal with Nscale - report
• Meta to pay up to $16.68 billion in mass social media settlement
• BioLife Solutions (BLFS)2600 contracts of September 40 puts trade